February 05, 2020 / 09:37 AM IST
Reported Standalone quarterly numbers for GlaxoSmithKline Pharmaceuticals are:Net Sales at Rs 778.68 crore in December 2019 down 5.65% from Rs. 825.35 crore in December 2018.
Story continues below Advertisement
Quarterly Net Loss at Rs. 644.14 crore in December 2019 down 670.19% from Rs. 112.97 crore in December 2018.
EBITDA stands at Rs. 140.90 crore in December 2019 down 8.35% from Rs. 153.74 crore in December 2018.
GlaxoSmithKline shares closed at 1,447.55 on February 04, 2020 (NSE) and has given 20.79% returns over the last 6 months and 3.09% over the last 12 months.
GlaxoSmithKline Pharmaceuticals | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'19 | Sep'19 | Dec'18 | Net Sales/Income from operations | 778.68 | 882.10 | 825.35 | Other Operating Income | -- | -- | -- | Total Income From Operations | 778.68 | 882.10 | 825.35 | EXPENDITURE | Consumption of Raw Materials | 112.45 | 94.56 | 184.91 | Purchase of Traded Goods | 238.64 | 130.05 | 226.77 | Increase/Decrease in Stocks | -23.34 | 145.26 | -29.10 | Power & Fuel | -- | -- | -- | Employees Cost | 166.69 | 147.47 | 125.55 | Depreciation | 18.33 | 22.70 | 12.04 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 159.59 | 170.52 | 179.90 | P/L Before Other Inc. , Int., Excpt. Items & Tax | 106.32 | 171.54 | 125.28 | Other Income | 16.25 | 15.61 | 16.42 | P/L Before Int., Excpt. Items & Tax | 122.57 | 187.15 | 141.70 | Interest | 2.98 | 0.92 | 0.05 | P/L Before Exceptional Items & Tax | 119.59 | 186.23 | 141.65 | Exceptional Items | -736.90 | 401.14 | 28.13 | P/L Before Tax | -617.31 | 587.37 | 169.78 | Tax | 26.83 | 84.58 | 56.81 | P/L After Tax from Ordinary Activities | -644.14 | 502.79 | 112.97 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -644.14 | 502.79 | 112.97 | Equity Share Capital | 169.41 | 169.41 | 169.40 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -38.02 | 29.68 | 6.67 | Diluted EPS | -38.02 | 29.68 | 6.67 | EPS After Extra Ordinary | Basic EPS | -38.02 | 29.68 | 6.67 | Diluted EPS | -38.02 | 29.68 | 6.67 | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!